A Quality-Adjusted Survival (Q-TWiST) Model for Evaluating Treatments for Advanced Stage Cancer

Journal of Biopharmaceutical Statistics

Volumn 14, Issue 1, 2004, Pages 111-124

  Cole, Bernard F ^a,e   Gelber, Richard D ^b,c   Gelber, Shari ^b   Mukhopadhyay, Pabak ^d  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Quality of life; Survival analysis

Indexed keywords

PROCARBAZINE; TEMOZOLOMIDE;

ADVANCED CANCER; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; DOSE RESPONSE; EVALUATION; GLIOMA; HEALTH STATUS; METHODOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STATISTICAL MODEL;

GLIOMA; HUMANS; MODELS, STATISTICAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS;

EID: 1542289007     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-120028509     Document Type: Review

References (13)

1. Aaronson, N. K., Cull, A. M., Kaasa, S., Sprangers, M. A. G. (1996). The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology: An update. In: Spilker, B., ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia: Lippincott-Raven, pp. 179-201.
2. Breslow, N., Crowley, J. (1974). A large sample study of the life table and product limit estimates under random censorship. Ann. Statist. 2:437-453.
3. Cole, B. F., Gelber, R. D., Goldhirsch, A. (1993). Cox regression models for quality adjusted survival analysis. Statist. Med. 12:975-987.
4. Cole, B. F., Gelber, R. D., Anderson, K. M., Goldhirsch, A. (1994). Parametric approaches to quality-adjusted survival analysis. Biometrics 50:621-631.
5. Fairclough, D. L. (2002). Design and Analysis of Quality of Life Studies in Clinical Trials. Boca Raton: Chapman and Hall/CRC Press.
6. Gelber, R. D., Gelman, R. S., Goldhirsch, A. (1989). A quality-of-life oriented endpoint for the evaluation of therapies. Biometrics 45:781-795.
7. Gelber, R. D., Cole, B. F., Gelber, S., Goldhirsch, A. (1996). The Q-TWiST method. In: Spilker, B., ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia: Lippincott-Raven, pp. 437-444.
8. Glasziou, P. P., Simes, R. J., Gelber, R. D. (1990). Quality adjusted survival analysis. Statist. Med. 9:1259-1276.
9. Glasziou, P. P., Cole, B. F., Gelber, R. D., Hilden, J., Simes, J. R. (1998). Quality adjusted survival analysis with repeated quality of life measures. Statist. Med. 17:1215-1229.
10. Kaplan, E. L., Meier, P. (1958). Nonparametric estimation from incomplete observations. J. Amer. Statist. Assoc. 54:457-481.
11. Osoba, D., Brada, M., Yung, W. K. A., Prados, M. (2000). Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. J. Clin. Oncol. 18:1481-1491.
12. Zhao, H., Tsiatis, A. A. (1997). A consistent estimator for the distribution of quality-adjusted survival time. Biometrika 84:339-348.
13. Zhao, H., Tsiatis, A. A. (2000). Estimating mean quality adjusted lifetime with censored data. Sankhya 62(Series B, Part 1):175-188.